US biotech Inovio (Nasdaq: INO) said it plans to offer and sell shares of its common stock in an underwritten public offering ...
Danish CNS specialist Lundbeck today announced results, that showed total revenue grew by +14% CER1 (+13% DKK) to 18,537 ...
Japan’s Otsuka has announced positive findings from a 12-month interim analysis of sibeprenlimab for the treatment of ...
Cambridge, USA-based AI-driven biotech Insilico Medicine has announced a research collaboration with Eli Lilly, under which ...
US biopharma Madrigal has announced positive two-year data from the open-label compensated metabolic dysfunction-associated ...
Canadian genetic medicines company enGene Holdings saw its shares rocket as much as 65% to $9.93 in pre-market trading, after ...
In today’s rapidly evolving healthcare landscape, the journey from scientific discovery to patient access is more complex ...
Switzerland’s Idorsia has announced the publication of a new analysis from the landmark Phase III PRECISION study.
The US regulator is removing boxed warnings for cardiovascular disease, breast cancer and dementia from hormone replacement ...
South Korea-based Samsung Epis Holdings today announced the establishment of Epis NexLab Co, a new subsidiary that will focus ...
There is growing recognition that middlemen, like pharmaceutical benefits managers (PBMs) and 340B hospitals, mark up ...
US contract development and manufacturing organization Avid Bioservices (Nasdaq: CDMO) has appointed Dave Stewart as chief technology and transformation officer, a newly created position that signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback